BATS BZX Real-Time Price
As of 10:01am ET
| +0.02 / +0.04%|
The 8 analysts offering 12-month price forecasts for Bristol-Myers Squibb Co have a median target of 55.50, with a high estimate of 66.00 and a low estimate of 46.00. The median estimate represents a +16.89% increase from the last price of 47.48.
The current consensus among 12 polled investment analysts is to Buy stock in Bristol-Myers Squibb Co. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.